SEC Form 4 · accession 0001144204-18-039093
Arch Therapeutics, Inc. · ARTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Punit Dhillon
Director
Period of report
Jul 19, 2018
Accepted (ET)
Jul 20, 2018 · 12:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001537561
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.425 | Jul 19, 2018 | A | 200,000 | A | — | Jul 18, 2028 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1Of the Shares subject to this Grant, 1/12th shall on each of the next twelve (12) monthly anniversaries of the vesting commencement date.